← Leaderboards
Calvin J Kuo
Stanford University
$48,363,495
Attributed
$62,060,524
Total exposure
29
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$81,667,662 · 31
By mechanism
R01$26,263,207 · 12
U01$25,896,982 · 6
U19$19,084,774 · 7
U54$10,422,699 · 6
Top collaborators
- Hanlee Ji14 shared
- Manuel R Amieva11 shared
- Kenan Christopher Garcia6 shared
- Trever G Bivona5 shared
- Christina N Curtis5 shared
- Kevan M. Shokat5 shared
- Olivier Gevaert4 shared
- John B Sunwoo4 shared
Most similar at Stanford University
Same institution · by research overlap
- Kari C. Nadeau$30,132,783
- John B Sunwoo$14,810,025
- Olivier Gevaert$8,099,347
- Asiri Ediriwickrema$254,424
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroCellsOrganoidsBasePathway InteractionsMalignant NeoplasmsGeneticSignal TransductionIntestinesTissuesResponseMediatingIn VivoGenesTumorLiquid SubstanceExhibitsPhenotype3-DimensionalReconstitutionHomeostasisColonImmuneSynergism
Grant awards (156)
Stanford/UNC Biomimetic U19 Research Center$1,466,585
U19 · FY2025 · AI · contact PI
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments$655,548
R01 · FY2025 · CA · contact PI
Impaired cellular RNA editing as a cause of inflammation in inflammatory bowel disease$451,487
R01 · FY2025 · DK
Mechanistic and Therapeutic Studies of GPR124/RECK/WNT7-Regulated Blood-Brain Barrier Function$437,495
R01 · FY2025 · NS · contact PI
Core B: Organoid Core$403,095
U19 · FY2025 · AI · contact PI
Core 2: Stanford Breast Metastasis Center Organoid Core$187,184
U54 · FY2025 · CA · contact PI
Core A: Administrative Core$143,113
U19 · FY2025 · AI · contact PI
TOOLKIT Core$68,325
U54 · FY2025 · CA · contact PI
Stanford/UNC Biomimetic U19 Research Center$1,484,612
U19 · FY2024 · AI · contact PI
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments$623,480
R01 · FY2024 · CA · contact PI
Core B: Organoid Core$452,832
U19 · FY2024 · AI · contact PI
Mechanistic and Therapeutic Studies of GPR124/RECK/WNT7-Regulated Blood-Brain Barrier Function$438,772
R01 · FY2024 · NS · contact PI
Impaired cellular RNA editing as a cause of inflammation in inflammatory bowel disease$429,230
R01 · FY2024 · DK
Core 2: Stanford Breast Metastasis Center Organoid Core$232,997
U54 · FY2024 · CA · contact PI
Core A: Administrative Core$165,270
U19 · FY2024 · AI · contact PI
TOOLKIT Core$71,324
U54 · FY2024 · CA · contact PI
Stanford/UNC Biomimetic U19 Research Center$1,501,000
U19 · FY2023 · AI · contact PI
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments$643,856
R01 · FY2023 · CA · contact PI
Core B: Organoid Core$530,054
U19 · FY2023 · AI · contact PI
Mechanistic and Therapeutic Studies of GPR124/RECK/WNT7-Regulated Blood-Brain Barrier Function$452,781
R01 · FY2023 · NS · contact PI
Investigation and Translation of the Intestinal Stem Cell Niche$404,070
U01 · FY2023 · DK · contact PI
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity$393,500
R01 · FY2023 · DK · contact PI
Core 2: Stanford Breast Metastasis Center Organoid Core$193,419
U54 · FY2023 · CA · contact PI
Core A: Administrative Core$165,105
U19 · FY2023 · AI · contact PI
TOOLKIT Core$83,944
U54 · FY2023 · CA · contact PI
Stanford/UNC Biomimetic U19 Research Center$1,511,551
U19 · FY2022 · AI · contact PI
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy$654,389
R01 · FY2022 · DK · contact PI
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments$643,552
R01 · FY2022 · CA · contact PI
Core B: Organoid Core$529,054
U19 · FY2022 · AI · contact PI
Investigation and Translation of the Intestinal Stem Cell Niche$403,787
U01 · FY2022 · DK · contact PI
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity$393,500
R01 · FY2022 · DK · contact PI
Core 2: Stanford Breast Metastasis Center Organoid Core$237,505
U54 · FY2022 · CA · contact PI
Core A: Administrative Core$163,287
U19 · FY2022 · AI · contact PI
TOOLKIT Core$80,174
U54 · FY2022 · CA · contact PI
Stanford/UNC Biomimetic U19 Research Center$1,559,276
U19 · FY2021 · AI · contact PI
Bay Area Team Against Resistance$1,149,528
U54 · FY2021 · CA
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms$946,646
U01 · FY2021 · CA · contact PI
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy$669,517
R01 · FY2021 · DK · contact PI
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments$657,944
R01 · FY2021 · CA · contact PI
Stanford Project 2$516,569
U54 · FY2021 · CA · contact PI
Core B: Organoid Core$410,250
U19 · FY2021 · AI · contact PI
Investigation and Translation of the Intestinal Stem Cell Niche$403,512
U01 · FY2021 · DK · contact PI
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity$393,625
R01 · FY2021 · DK · contact PI
Regulation of Blood-Brain Barrier Function by the RECK/GPR124/Wnt7 Pathway$354,964
R01 · FY2021 · NS · contact PI
Core 2: Stanford Breast Metastasis Center Organoid Core$263,348
U54 · FY2021 · CA · contact PI
Core A: Administrative Core$165,402
U19 · FY2021 · AI · contact PI
TOOLKIT Core$143,721
U54 · FY2021 · CA · contact PI
Bay Area Team Against Resistance$1,185,025
U54 · FY2020 · CA
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms$946,509
U01 · FY2020 · CA · contact PI
Human Lung Organoid Models of SARS-CoV-2 Infection$900,000
U19 · FY2020 · AI · contact PI
Organoid Core B$900,000
U19 · FY2020 · AI · contact PI
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy$684,190
R01 · FY2020 · DK · contact PI
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy$553,964
R01 · FY2020 · DK · contact PI
Stanford Project 2$532,885
U54 · FY2020 · CA · contact PI
Investigation and Translation of the Intestinal Stem Cell Niche$403,235
U01 · FY2020 · DK · contact PI
Regulation of Blood-Brain Barrier Function by the RECK/GPR124/Wnt7 Pathway$354,948
R01 · FY2020 · NS · contact PI
Bay Area Team Against Resistance$1,277,605
U54 · FY2019 · CA
Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases$1,002,662
U19 · FY2019 · AI · contact PI
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms$917,988
U01 · FY2019 · CA · contact PI
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids$900,713
U01 · FY2019 · CA · contact PI
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy$698,412
R01 · FY2019 · DK · contact PI
Stanford Project 2$566,735
U54 · FY2019 · CA · contact PI
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids$499,437
U01 · FY2019 · CA · contact PI
Investigation and Translation of the Intestinal Stem Cell Niche$402,983
U01 · FY2019 · DK · contact PI
Regulation of Blood-Brain Barrier Function by the RECK/GPR124/Wnt7 Pathway$354,933
R01 · FY2019 · NS · contact PI
Administrative Core A$349,275
U19 · FY2019 · AI · contact PI
Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases$1,004,473
U19 · FY2018 · AI · contact PI
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms$946,251
U01 · FY2018 · CA · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$924,971
U01 · FY2018 · DE
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids$876,328
U01 · FY2018 · CA · contact PI
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy$688,498
R01 · FY2018 · DK · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$372,124
U01 · FY2018 · DK · contact PI
Regulation of Blood-Brain Barrier Function by the RECK/GPR124/Wnt7 Pathway$354,917
R01 · FY2018 · NS · contact PI
Administrative Core A$342,661
U19 · FY2018 · AI · contact PI
Bay Area Team Against Resistance$140,000
U54 · FY2018 · CA
Regulation of actively proliferating and quiescent intestinal stem cells$81,988
U01 · FY2018 · DK · contact PI
Bay Area Team Against Resistance$2,401,042
U54 · FY2017 · CA
Stanford Project 2$1,091,369
U54 · FY2017 · CA · contact PI
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids$1,026,181
U01 · FY2017 · CA · contact PI
Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases$1,006,235
U19 · FY2017 · AI · contact PI
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms$946,126
U01 · FY2017 · CA · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$924,971
U01 · FY2017 · DE
Regulation of actively proliferating and quiescent intestinal stem cells$372,124
U01 · FY2017 · DK · contact PI
Regulation of Blood-Brain Barrier Function by the RECK/GPR124/Wnt7 Pathway$355,409
R01 · FY2017 · NS · contact PI
Administrative Core A$343,694
U19 · FY2017 · AI · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$82,999
U01 · FY2017 · DK · contact PI
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids$1,016,593
U01 · FY2016 · CA · contact PI
Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases$1,007,943
U19 · FY2016 · AI · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$947,802
U01 · FY2016 · DE
Functional Analysis of Oncogenic Networks in Primary Organoids$909,785
U01 · FY2016 · CA · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$372,124
U01 · FY2016 · DK · contact PI
Administrative Core A$282,102
U19 · FY2016 · AI · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$84,460
U01 · FY2016 · DK · contact PI
Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases$1,009,601
U19 · FY2015 · AI · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$969,709
U01 · FY2015 · DE
Functional Analysis of Oncogenic Networks in Primary Organoids$854,573
U01 · FY2015 · CA · contact PI
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci$538,250
U01 · FY2015 · CA · contact PI
miR-126 Regulation of Tumor Progression$391,080
R01 · FY2015 · CA · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$371,530
U01 · FY2015 · DK · contact PI
Administrative Core A$285,642
U19 · FY2015 · AI · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$87,264
U01 · FY2015 · DK · contact PI
Functional Analysis of Oncogenic Networks in Primary Organoids$893,517
U01 · FY2014 · CA · contact PI
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci$523,201
U01 · FY2014 · CA · contact PI
miR-126 Regulation of Tumor Progression$378,624
R01 · FY2014 · CA · contact PI
Regulation of actively proliferating and quiescent intestinal stem cells$372,124
U01 · FY2014 · DK · contact PI
Regulation of Adult CNS Angiogenesis by GPR124$349,066
R01 · FY2014 · NS · contact PI
Functional Analysis of Oncogenic Networks in Primary Organoids$940,609
U01 · FY2013 · CA · contact PI
Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture$677,466
R01 · FY2013 · DK · contact PI
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci$507,962
U01 · FY2013 · CA · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$388,758
U01 · FY2013 · DK · contact PI
miR-126 Regulation of Tumor Progression$366,262
R01 · FY2013 · CA · contact PI
Regulation of Adult CNS Angiogenesis by GPR124$339,895
R01 · FY2013 · NS · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$65,628
U01 · FY2013 · DK · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$51,072
U01 · FY2013 · DK · contact PI
Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture$714,549
R01 · FY2012 · DK · contact PI
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci$541,494
U01 · FY2012 · CA · contact PI
miR-126 Regulation of Tumor Progression$389,012
R01 · FY2012 · CA · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$386,728
U01 · FY2012 · DK · contact PI
Regulation of Adult CNS Angiogenesis by GPR124$354,085
R01 · FY2012 · NS · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$149,788
U01 · FY2012 · DK · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$23,550
U01 · FY2012 · DK · contact PI
Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture$714,549
R01 · FY2011 · DK · contact PI
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci$537,462
U01 · FY2011 · CA · contact PI
miR-126 Regulation of Tumor Progression$388,896
R01 · FY2011 · CA · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$387,238
U01 · FY2011 · DK · contact PI
Regulation of Adult CNS Angiogenesis by GPR124$355,968
R01 · FY2011 · NS · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$158,579
U01 · FY2011 · DK · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$15,940
U01 · FY2011 · DK · contact PI
Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture$728,106
R01 · FY2010 · DK · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$387,730
U01 · FY2010 · DK · contact PI
Regulation of Adult CNS Angiogenesis by GPR124$358,895
R01 · FY2010 · NS · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$189,677
U01 · FY2010 · DK · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$36,763
U01 · FY2010 · DK · contact PI
Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture$900,000
R01 · FY2009 · DK · contact PI
In vivo and in vitro Characteization of BMI1 + Intestinal Stem Cells$404,129
U01 · FY2009 · DK · contact PI
VEGF Regulation of Hepatic Erythropoietin Synthesis$342,488
R01 · FY2009 · HL · contact PI
Wnt Proteins During Intestinal Repair and Regeneration$290,900
R01 · FY2009 · DK · contact PI
VEGF Regulation of Hepatic Erythropoietin Synthesis$187,911
R01 · FY2009 · HL · contact PI
Regulation of CNS Angiogenesis By GPR124$137,293
R01 · FY2009 · NS · contact PI
VEGF Regulation of Hepatic Erythropoietin Synthesis$336,170
R01 · FY2008 · HL · contact PI
Regulation of CNS Angiogenesis By GPR124$335,351
R01 · FY2008 · NS · contact PI
Wnt Proteins During Intestinal Repair and Regeneration$290,861
R01 · FY2008 · DK · contact PI
VEGF Regulation of Hepatic Erythropoietin Synthesis$336,124
R01 · FY2007 · HL · contact PI
Regulation of CNS Angiogenesis By GPR124$335,541
R01 · FY2007 · NS · contact PI
Wnt Proteins During Intestinal Repair and Regeneration$296,762
R01 · FY2007 · DK · contact PI
VEGF Regulation of Hepatic Erythropoietin Synthesis$346,122
R01 · FY2006 · HL · contact PI
Regulation of CNS Angiogenesis By GPR124$345,700
R01 · FY2006 · NS · contact PI
VEGF-dependent and - Independent Anti-angiogenic Therapy$309,383
R01 · FY2006 · CA · contact PI
Wnt Proteins During Intestinal Repair and Regeneration$305,588
R01 · FY2006 · DK · contact PI
VEGF Regulation of Hepatic Erythropoietin Synthesis$385,099
R01 · FY2005 · HL
Regulation of CNS Angiogenesis By GPR124$340,185
R01 · FY2005 · NS
VEGF-dependent and - Independent Anti-angiogenic Therapy$316,829
R01 · FY2005 · CA
Wnt Proteins During Intestinal Repair and Regeneration$306,799
R01 · FY2005 · DK
VEGF-dependent and - Independent Anti-angiogenic Therapy$316,829
R01 · FY2004 · CA
VEGF-dependent and - Independent Anti-angiogenic Therapy$316,829
R01 · FY2003 · CA
VEGF-dependent and - Independent Anti-angiogenic Therapy$339,079
R01 · FY2002 · CA